Neuroscience and Pharmacology Meet Law

For more than 25 years, our research in addiction and psychiatric disorders has informed high-stakes decisions. We translate this expertise into clear, reliable guidance for litigation involving psychoactive medications and neuropsychiatric conditions.

​

Richard De La Garza, II, Ph.D. is​ a neuroscientist specializing in the neurobiology of addiction, psychiatric illness, and psychopharmacology, with extensive experience analyzing the mechanisms, safety profiles, and real-world impacts of medications affecting the central nervous system. His academic and professional background includes advanced research on brain chemistry related to addiction, depression, anxiety, and PTSD, as well as extensive work in medication development and testing for drug use disorders. This foundation enables him to synthesize complex scientific literature, evaluate clinical, toxicological and pharmacokinetic data, and provide clear, authoritative opinions on issues involving drug effects, misuse liability, behavioral outcomes, and causation.